On the contrary, Golan T and his colleagues found that human Fzd6 could act as a negative regulator of the Wnt/β‐cat signaling by inhibiting the ability of β‐catenin to activate the transcription in human 293 T and cancer cell lines.22 The gene discussed is FZD6; the disease is cancer.